EFFECTS OF TRIFLUOPERAZINE IN AGED DEPRESSED FEMALE PATIENTS
Abstract
It would appear that the incidence and severity of Parkinsonism in this age group is so high that trifluoperazine should be used very cautiously. Occurrence of 1 very dramatic recovery and 3 cases of gratifying improvement suggest that trifluoperazine may be useful in cases of chronic depression resistant to more usual therapies.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
